WO1998004725A1 - Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues - Google Patents
Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues Download PDFInfo
- Publication number
- WO1998004725A1 WO1998004725A1 PCT/US1997/013358 US9713358W WO9804725A1 WO 1998004725 A1 WO1998004725 A1 WO 1998004725A1 US 9713358 W US9713358 W US 9713358W WO 9804725 A1 WO9804725 A1 WO 9804725A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- altered
- amount
- dna
- methylated dna
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 145
- 230000008121 plant development Effects 0.000 title description 5
- 230000035800 maturation Effects 0.000 claims abstract description 45
- 230000001965 increasing effect Effects 0.000 claims abstract description 30
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000011161 development Methods 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims description 308
- 108090000623 proteins and genes Proteins 0.000 claims description 52
- 108060004795 Methyltransferase Proteins 0.000 claims description 50
- 230000000692 anti-sense effect Effects 0.000 claims description 50
- 102000016397 Methyltransferase Human genes 0.000 claims description 37
- 241000219194 Arabidopsis Species 0.000 claims description 27
- 230000004075 alteration Effects 0.000 claims description 24
- 230000009467 reduction Effects 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 230000002829 reductive effect Effects 0.000 claims description 10
- 101150031330 metl gene Proteins 0.000 claims description 9
- 239000002028 Biomass Substances 0.000 claims description 8
- 108020004999 messenger RNA Proteins 0.000 claims description 7
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 230000000295 complement effect Effects 0.000 claims 2
- 230000007067 DNA methylation Effects 0.000 abstract description 20
- 230000003247 decreasing effect Effects 0.000 abstract description 18
- 108020004414 DNA Proteins 0.000 description 95
- 210000004027 cell Anatomy 0.000 description 43
- 239000013598 vector Substances 0.000 description 20
- 230000011987 methylation Effects 0.000 description 17
- 238000007069 methylation reaction Methods 0.000 description 17
- 241000589158 Agrobacterium Species 0.000 description 15
- 239000013612 plasmid Substances 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 14
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 229940104302 cytosine Drugs 0.000 description 12
- 230000009466 transformation Effects 0.000 description 12
- 108700019146 Transgenes Proteins 0.000 description 11
- 230000017858 demethylation Effects 0.000 description 11
- 238000010520 demethylation reaction Methods 0.000 description 11
- 229930027917 kanamycin Natural products 0.000 description 10
- 229960000318 kanamycin Drugs 0.000 description 10
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 10
- 229930182823 kanamycin A Natural products 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 210000001938 protoplast Anatomy 0.000 description 8
- 230000030933 DNA methylation on cytosine Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 7
- 108090000992 Transferases Proteins 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 230000035784 germination Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 5
- 102000004357 Transferases Human genes 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 210000002230 centromere Anatomy 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000013605 shuttle vector Substances 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 4
- 108020001027 Ribosomal DNA Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 231100001222 nononcogenic Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 235000003228 Lactuca sativa Nutrition 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 108020005120 Plant DNA Proteins 0.000 description 3
- 244000300264 Spinacia oleracea Species 0.000 description 3
- 235000009337 Spinacia oleracea Nutrition 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- BJDCWCLMFKKGEE-CMDXXVQNSA-N chembl252518 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-CMDXXVQNSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000030279 gene silencing Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000010198 maturation time Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000026694 meristem determinacy Effects 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036178 pleiotropy Effects 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 2
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
- 102000055027 Protein Methyltransferases Human genes 0.000 description 2
- 108700040121 Protein Methyltransferases Proteins 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 108091035233 repetitive DNA sequence Proteins 0.000 description 2
- 102000053632 repetitive DNA sequence Human genes 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 1
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 102100022087 Granzyme M Human genes 0.000 description 1
- 101000900697 Homo sapiens Granzyme M Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- VPRLICVDSGMIKO-UHFFFAOYSA-N Mannopine Natural products NC(=O)CCC(C(O)=O)NCC(O)C(O)C(O)C(O)CO VPRLICVDSGMIKO-UHFFFAOYSA-N 0.000 description 1
- 206010068052 Mosaicism Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001633102 Rhizobiaceae Species 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 229960002756 azacitidine Drugs 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000000453 cell autonomous effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 1
- 239000004062 cytokinin Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- VPRLICVDSGMIKO-SZWOQXJISA-N mannopine Chemical compound NC(=O)CC[C@@H](C(O)=O)NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VPRLICVDSGMIKO-SZWOQXJISA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 101150077837 meT1 gene Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000008775 paternal effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000000745 plant chromosome Anatomy 0.000 description 1
- 230000008638 plant developmental process Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/827—Flower development or morphology, e.g. flowering promoting factor [FPF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- Plant genomes contain relatively large amounts of the modified nucleotide
- ddm mutants exhibit a slight delay (1.7 days) in flowering, altered
- a reduction in the rate a plant matures can be used to increase the biomass
- the present invention is based on the unexpected observation that a decrease
- DNA present in a plant genome results in a plant that requires less time to mature.
- the rate of maturation is increased by altering the plant
- plant cells plant tissues or plant seeds, using molecular techniques, such that the plant
- the rate of maturation is decreased by altering a plant, plant cells, plant tissues or plant seeds, using molecular
- the present invention further provides plants that have an altered rate of
- Figure 1 The predicted MET1 gene product and antisense construct.
- the METJ protein is a 1,534-amino acid protein with a high degree
- MET! antisense construct is shown in the bottom of the figure. See Example 1.
- mutants were digested with Hpa II (left panels) or Msp I (right panels), subjected to
- LEAFY LFY
- Tr246 to wild-type Arabidopsis Cold-type Arabidopsis (Columbia strain with no mutations) were digested
- the present invention is based on the unexpected observation that DNA
- methylation particularly at cytosine nucleotides, is involved in regulating the rate of
- the present invention is based on the
- the present invention provides methods for
- maturation refers to the process of plant differentiation leading
- the method will produce plants with an increased
- Arabidopsis plants were obtained which developed flowers after 10 to 12 days.
- the result of accelerating plant development is the ability to decrease the
- biomass refers to the total plant weight, particularly leafy material. The amount of leaf material is increased in plants altered
- Another consequence of delaying flower production is to produce plants that
- plants propagated containing the genetic alteration can be used in the present method. Methods known in the art for molecularly altering a plant are discussed in detail
- the preferred plants include both dicot and monocotyledonous plants.
- most preferred plants are plants with economic value as a food or biomass source, or
- plants with long maturation times Such plants include, but are not limited to, leafy
- plants such as tobacco, spinach, lettuce, and seed bearing plants such as rice, corn, soy
- the methods of the present invention rely on altering plants using molecular
- non-molecular methods namely selecting plants generated through methods such as
- plants and plant cells can be subjected to chemical mutagenesis, physical mutagenesis
- Plants can then be
- the methods of the present invention can be used to alter
- a plant is said to have a reduced or decreased amount of
- methylated DNA when the plant has less methylated DNA than the non-altered plant.
- cytosine has been seen to be methylated in plants.
- present methods are therefore accomplished by targeting the methylation of cytosine.
- cytosine were obtained.
- targets, strategies and molecular techniques can be used by a variety of targets, strategies and molecular techniques.
- methyl transferases that are normally produced in the plant.
- the methyl transferase can be altered in a variety of ways by a skilled artisan
- Any of a plant's DNA methyl transferases genes can be used as a target in the
- the most preferred targets are the genes encoding a cytosine methyl
- DNA methyl transferase genes examples include
- cytosine methyltransferase such as the MET1 Arabidopsis gene herein used, the
- plant is to create knockout mutants in the plant in which one or more of the plant's
- DNA methyl transferase genes are inactivated. This can be accomplished through the
- transposon mediated mutagenesis can be used for the same purpose.
- transferase gene allowing one to activate or deactivate methyl transferase expression
- the methods of the present invention can be used to alter
- a plant is said to have a reduced or decreased amount of
- methylated DNA when the plant has less methylated DNA than the non-altered plant.
- cytosine has been seen to be methylated in plants.
- present methods are therefore accomplished by targeting the methylation of cytosine.
- methyl transferase in the plant cell.
- the methyl transferase can be altered in a variety of ways by a
- DNA methyl transferase encoding expression units can be any suitable DNA methyl transferase encoding expression units.
- DNA methyl transferase encoding expression units can be any suitable DNA methyl transferase encoding expression units.
- expression units can be controlled either by a constitutive promoter, providing
- Any DNA methyl transferase gene, or active fragment thereof, can be used to generate a stable copy of a gene.
- DNA can be further altered so as to contain an expression unit that expresses a DNA
- plants are of additional value because of the ability to induce expression of a DNA
- the present invention further provides plants that have been altered using
- the plants of the present invention fall within two types.
- the first type is a first type
- plants of the present invention that have a slower rate of maturation will mature at a
- plants or the present invention include those that have been altered, using
- the preferred plants are plants for which it is desirable to reduce generation times for breeding or seed production
- expression units or expression vectors or systems to express an exogenously
- a supplied gene such as a DNA methyl transferase, or antisense molecule, in a plant.
- methylated DNA present in a plant cell typically employ a protein or
- antisense coding region such as the METl Arabidopsis gene, or a homologue thereof
- antisense coding region can either be the expression control element that is
- Transcription initiation regions can include any of the various opine
- initiation regions such as octopine, mannopine, nopaline and the like that are found in
- plant promoters such as prolifera promoter,
- promoters etc. can also be used. The most preferred promoters will be active in
- tissue particularly meristematic cells.
- Either a constitutive promoter such as the CaMV or Nos promoter illustrated above, an organ-specific promoter (such as the E8 promoter from tomato) or an
- inducible promoter is typically ligated to the protein or antisense encoding region
- the expression unit may be further
- the expression units will typically contain, in
- restriction enzyme sites at the 5' and 3' ends of the expression unit are typically
- the promoter is
- the expression cassette can also contain a promoter sequence
- the termination region may be obtained from the same gene as
- the promoter sequence or may be obtained from different genes. If the mRNA
- Polyadenylation sequences include, but are not limited to the Agrobacterium octopine
- the resulting expression unit is ligated into or otherwise constructed to be included in a vector which is appropriate for higher plant transformation.
- the vector will also typically contain a selectable marker gene by which transformed plant cells
- the marker gene can be identified in culture.
- the marker gene will encode antibiotic
- markers include resistance to G418, hygromycin, bleomycin,
- vector will be identified by their ability to grow on a medium containing the particular
- Replication sequences of bacterial or viral origin, are generally also
- a vector included to allow the vector to be cloned in a bacterial or phage host, preferably a
- bacteria should also be included to allow selection of bacterial cells bearing the
- Suitable prokaryotic selectable markers also include resistance to
- antibiotics such as kanamycin or tetracycline.
- T-DNA sequences will also be included for subsequent transfer to
- plants having an altered amount of methylated DNA can be produced by:
- a plant may also be used in the present methods. For example, formation of a triple
- photocrosslinking is described, e.g., in D. Praseuth, et al, Proc. Nat 'I Acad. Sci. USA
- transgenic plants are prepared which contain the desired expression unit or into which
- the vector is microinjected directly into plant cells by use of
- micropipettes to mechanically transfer the recombinant DNA into the plant cell
- nucleic acid either within the matrix of small beads or particles, or on the
- These entities are minicells, cells, lysosomes or other fusible lipid-surfaced
- DNA may also be introduced into the plant cells by electroporation (From et
- the cell wall divide, and regenerate.
- a plant cell For transformation mediated by bacterial infection, a plant cell is infected with
- Agrobacterium is a representative genus of the gram-negative family
- Rhizobiaceae Its species are responsible for crown gall (A. tumefaciens) and hairy
- the bacterial genes responsible for expression of opines are a
- assaying for the presence of opines can be used to identify transformed tissue.
- Heterologous genetic sequences can be introduced into appropriate plant cells,
- Ti or Ri plasmid is transmitted to plant cells on infection by Agrobacterium and is
- Ti and Ri plasmids contain two regions essential for the production of transformed
- T-DNA transferred DNA
- the other termed the virulence (yir) region, is
- the T-DNA will be any substance that is essential for the transfer of the T-DNA but is not itself transferred.
- the T-DNA will be any substance that is not be transferred.
- the transferred DNA region can be transferred into a plant cell even if the yji region is on a different plasmid (Hoekema, et al, Nature 303: 179-189 (1983)).
- the transferred DNA region can be
- plasmids and sometimes constructed from foreign sequences. These may include but
- co-integrate the shuttle vector containing the gene of
- the gene of interest is inserted into a shuttle vector containing the cz ' -v-acting elements required for plant transformation.
- the other necessary functions are
- the second method requires (a) that the intact plant tissues, such as
- cotyledons can be transformed by Agrobacterium and (b) that the transformed cells
- Plant cells which have been transformed can also be regenerated using known
- Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing transformed explants
- Callus tissue is formed and shoots may be induced from callus and
- somatic embryo formation can be induced in the
- the culture media will generally contain various amino acids and plant hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proline
- silencing inactivation of transgenes is known as silencing.
- T-DNA vector pMON530 (Monsanto) in the antisense orientation to the CaMV 35S
- T-DNA confers resistance to kanamycin (50 ⁇ g/mi) on transgenic plants.
- PROLIFERA PRL
- CONSTITUTIVELY PHOTOMORPHOGENIC 1 CO
- ERECTA ER
- Tr246 to wild-type Arabidopsis Cold-type Arabidopsis (Columbia strain with no mutations) were digested
- the METl gene represents one member of a
- METl gene is expressed in seedling, vegetative, and floral tissues; in the
- T-DNA single-locus transferred DNA
- g/1 locus as a marker (but otherwise wild type), except as noted by Agrobacterium-
- the plants used in this study represent the kanamycin-resistant progeny of TI outcrosses from single-locus lines Tr242, 243, 244, 245, and 248.
- Seedlings were transplanted into soil 8 days after germination.
- Genomic DNAs were digested with the isochizomers Hpa II or Msp I (Fig.
- Msp I can cleave C 5m CGC but not 5m CCGG (M. Nelson, et ⁇ l, Nucleic
- genomic DNAs were isolated from plants immediately after the onset of flowering,
- Spherical Microsorb C18 column (100 A pore size, 4.5 mm inner diameter by 15 cm length) with a 20 min. isocratic gradient of 2.5% methanol, 50 mM KH,PO 5 (pH 4.0),
- Tr248 was reduced 71% relative to wild-type levels; the weak line Tr245 showed a
- antisense lines was determined by reversed-phase HPLC using the method of Gehrke
- Tr248 1.83 ⁇ 0.16 28.7 71.3 ddml 1.60 ⁇ 0.04 25.0 75.0
- Flowering time refers to the number of days elapsed from seed germination until emergence of an inflorescence bolt 0.5 to 1.0 cm
- leaf number refers to the number of vegetative leaves initiated before
- Tr242 24.5 ⁇ 2.1 10.0 ⁇ 1.4 4.5 ⁇ 1.1
- Tr248 46.3 ⁇ 4.7 32.9 ⁇ 2.7 20.5 ⁇ 2.0
- Tr242, 243, 244, 245, and 248 were plated on MS
- Tr244, Tr246 and Tr248 plants initiated 30 to 35 vegetative nodes with delayed abaxial trichome production and flowered after 45 to 48 days
- vegetative rosettes including enhanced spiral phyllotaxy of 10 to 20 vegetative-like
- tertiary inflorescences showed gross abnormalities, including a threefold increase in
- MTase differs markedly from the phenotype produced by the treatment of Arabidopsis
- 5-AzaC produces early flowering in some late-flowering strains and mutants of Arabidopsis (J. E. Burn, et al, Proc.
- Methylation may serve as a primary signal to restrict meristem determinacy, or it may
- phase transitions are often irregular in strong antisense plan — the location of
- branches apical to flowers in the inflorescence transition zone may represent an
- plants were altered to contain an expression unit that expresses cytosine methyl transferase under the control of the CaMV 355 promoter or another plant promoter.
- the expression units were introduced into a plant using Agrobacterium as
- plants having an increased amount of methylated DNA produced flowers at 10 to 12
- the present methods can be applied to any plant that can be altered using
- the first step in applying the present methods is to select as
- the plant is altered so as to contain an increased amount of methylated DNA while to
- the second step may be to decide which method to employ to alter the plant.
- the amount of DNA methylation can be decreased by inactivating
- methylation can be increased by activating or increasing the methylase activity within
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Physiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU40480/97A AU730644B2 (en) | 1996-07-31 | 1997-07-30 | Methods for altering the rate of plant development and plants obtained therefrom |
EP97938066A EP0935666A1 (fr) | 1996-07-31 | 1997-07-30 | Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues |
CA002262779A CA2262779A1 (fr) | 1996-07-31 | 1997-07-30 | Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2331496P | 1996-07-31 | 1996-07-31 | |
US60/023,314 | 1996-07-31 | ||
US08/902,902 US6011200A (en) | 1997-07-30 | 1997-07-30 | Methods for altering the rate of plant development and plants obtained therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998004725A1 true WO1998004725A1 (fr) | 1998-02-05 |
Family
ID=26696969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/013358 WO1998004725A1 (fr) | 1996-07-31 | 1997-07-30 | Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1998004725A1 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999055891A1 (fr) * | 1998-04-30 | 1999-11-04 | Washington University | Gene vegetal regulant la methylation de l'adn |
WO2001000801A3 (fr) * | 1999-06-23 | 2001-05-10 | Syngenta Participations Ag | Gene intervenant dans l'inhibition epigenetique d'un gene |
WO2001009299A3 (fr) * | 1999-07-30 | 2001-08-23 | Univ Bath | Plantes modifiees |
EP1082417A4 (fr) * | 1998-06-04 | 2006-08-23 | Univ Queensland | Sequences genetiques modifiant le phenotype |
US7125857B2 (en) | 1997-08-29 | 2006-10-24 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
WO2005038040A3 (fr) * | 2003-10-14 | 2006-11-09 | Ceres Inc | Procedes et compositions permettant de modifier les phenotypes des semences |
US7429692B2 (en) | 2004-10-14 | 2008-09-30 | Ceres, Inc. | Sucrose synthase 3 promoter from rice and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014414A1 (fr) * | 1994-11-02 | 1996-05-17 | John Innes Centre Innovations Limited | Regulation genetique du fleurissement |
DE4444460A1 (de) * | 1994-11-29 | 1996-05-30 | Inst Genbiologische Forschung | Verfahren zur Steigerung des Ertrags sowie zur Veränderung des Blühverhaltens bei Pflanzen |
-
1997
- 1997-07-30 WO PCT/US1997/013358 patent/WO1998004725A1/fr not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014414A1 (fr) * | 1994-11-02 | 1996-05-17 | John Innes Centre Innovations Limited | Regulation genetique du fleurissement |
DE4444460A1 (de) * | 1994-11-29 | 1996-05-30 | Inst Genbiologische Forschung | Verfahren zur Steigerung des Ertrags sowie zur Veränderung des Blühverhaltens bei Pflanzen |
Non-Patent Citations (7)
Title |
---|
FINNEGAN, E.J., ET AL .: "ISOLATION AND IDENTIFICATION BY SEQUENCE HOMOLOGY OF A PUTATIVE CYTOSINE METHYLTRANSFERASE FROM ARABIDOPSIS THALIANA", NUCLEIC ACID RESEARCH, vol. 21, no. 10, 1993, pages 2383 - 2388, XP002049120 * |
FINNEGAN, E.J., ET AL.: "REDUCED DNA METHYLATION IN ARABIDOPSIS THALIANA RESULTS IN ABNORMAL PLANT DEVELOPMENT", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 93, August 1996 (1996-08-01), pages 8449 - 8454, XP002049122 * |
FINNEGAN, E.J.: "THE ROLE OF DNA METHYLATION IN PLANT DEVELOPMENT", EPIGENETIC MECHANISMS OF GENE REGULATION, vol. 32, 1996, COLD SPRING HARBOUR LABORATORY PRESS, pages 127 - 140, XP002049579 * |
KAKUTANI, T., ET AL .: "CHARACTERIZATION OF AN ARABIDOPSIS THALIANA DNA HYPOMETHYLATION MUTANT", NUCLEIC ACID RESEARCH, vol. 23, no. 1, 1995, pages 130 - 137, XP002049118 * |
RICHARDS, E.J., ET AL.: "DNA METHYLATION AND PLANT DEVELOPMENT", TRENDS IN GENETICS, vol. 13, no. 8, August 1997 (1997-08-01), pages 319 - 323, XP002049123 * |
RONEMUS, M.J., ET AL.: "DEMETHYLATION-INDUCED DEVELOPMENTAL PLEIOTROPY IN ARABIDOPSIS", SCIENCE, vol. 273, 2 August 1996 (1996-08-02), pages 654 - 657, XP002049121 * |
VONGS, A., ET AL.: "ARABIDOPSIS THALIANA DNA METHYLATION MUTANTS", SCIENCE, vol. 260, 25 July 1993 (1993-07-25), pages 1926 - 1928, XP002049119 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125857B2 (en) | 1997-08-29 | 2006-10-24 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
US7138384B1 (en) | 1997-08-29 | 2006-11-21 | The Regents Of The University Of California | Modulators of DNA cytosine-5 methyltransferase and methods for use thereof |
WO1999055891A1 (fr) * | 1998-04-30 | 1999-11-04 | Washington University | Gene vegetal regulant la methylation de l'adn |
EP1082417A4 (fr) * | 1998-06-04 | 2006-08-23 | Univ Queensland | Sequences genetiques modifiant le phenotype |
WO2001000801A3 (fr) * | 1999-06-23 | 2001-05-10 | Syngenta Participations Ag | Gene intervenant dans l'inhibition epigenetique d'un gene |
WO2001009299A3 (fr) * | 1999-07-30 | 2001-08-23 | Univ Bath | Plantes modifiees |
EP1690943A1 (fr) * | 1999-07-30 | 2006-08-16 | University Of Bath | Plantes mofidiées |
US7759546B2 (en) | 1999-07-30 | 2010-07-20 | University Of Bath | Methods for modifying plant endosperm |
WO2005038040A3 (fr) * | 2003-10-14 | 2006-11-09 | Ceres Inc | Procedes et compositions permettant de modifier les phenotypes des semences |
US7429692B2 (en) | 2004-10-14 | 2008-09-30 | Ceres, Inc. | Sucrose synthase 3 promoter from rice and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scheid et al. | Reversible inactivation of a transgene in Arabidopsis thaliana | |
DE60017781T2 (de) | Modulation der antwort einer pflanze auf abscisin säure | |
JP3782106B2 (ja) | 開花の遺伝的制御 | |
US8129588B2 (en) | Regulatory sequences for expressing gene products in plant reproductive tissue | |
US6248937B1 (en) | Transcription factor and method for regulation of seed development, quality and stress-tolerance | |
JP2000507446A (ja) | シングルステップ切出し手段 | |
EP4234701A2 (fr) | Régénération de plantes génétiquement modifiées | |
CA2684962C (fr) | Manipulation de senescence dans les plantes a l'aide de promoteurs modifies | |
US6011200A (en) | Methods for altering the rate of plant development and plants obtained therefrom | |
JPH08508412A (ja) | エチレンに対する修正された応答をもつ植物 | |
AU2006303820B2 (en) | Cereals with altered dormancy | |
AU2001241905A1 (en) | Transgenic plants with increased seed yield, biomass and harvest index | |
CN101048507B (zh) | 一种增大种子大小的方法 | |
WO1998004725A1 (fr) | Procedes de modification de la vitesse de croissance de plantes et plantes ainsi obtenues | |
Dehio et al. | Stable expression of a single-copy rolA gene in transgenic Arabidopsis thaliana plants allows an exhaustive mutagenic analysis of the transgene-associated phenotype | |
AU2001283715A1 (en) | Manipulation of plant senescence using an MYB gene promoter and cytokinin biosynthesis genes | |
WO2002020772A1 (fr) | Manipulation de senescence de plantes au moyen d'un promoteur de gene myb et de genes de biosynthese de la cytokinine | |
AU730644B2 (en) | Methods for altering the rate of plant development and plants obtained therefrom | |
US7265264B2 (en) | Gene for a Dof transcription factor capable of altering the size and stature of a plant | |
Oono et al. | Effects of the over-expression of the rolC gene on leaf development in transgenic periclinal chimeric plants | |
JP2000050873A (ja) | ペチュニアの転写因子PetSPL2の遺伝子の導入によって花序の節間を短縮させる方法 | |
WO2001000834A1 (fr) | Gene jouant un role dans la fertilite male chez les plantes | |
JP2000513218A (ja) | 植物におけるオーキシンの極性輸送の遺伝学的制御ならびに植物の成長、構造及び形態形成の操作 | |
US5750873A (en) | Nucleic acid molecules that encode tassel seed 2(TS2), a protein involved in the control of flower development in plants | |
Attia et al. | Transformation and functional expression of the rFCA‐RRM2 gene in rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2262779 Country of ref document: CA Kind code of ref document: A Ref document number: 2262779 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 334418 Country of ref document: NZ Ref document number: 1997938066 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref document number: 1998509110 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997938066 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997938066 Country of ref document: EP |